|
The patient¿s attorney alleged a deficiency against the device.The product was used for a laparoscopic therapeutic treatment of an bilateral inguinal hernia.It was reported that after implant, the patient experienced pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, inflammation, mesh migration, failure of mesh, adhesions, abdominal pain, tenderness, phleboliths (calcified thrombi), crampy abdominal pain, nausea, entrapped nerve syndrome, low back pain, hip pain, and muscle spasm.Post-operative patient treatment included revision surgery, laparoscopy with lysis of adhesions, mesh intervention surgery, x-ray, tap block, ultrasound, and fluoroscopy.Concomitant device: absorbatac stapler.
|
|
H6.Ime e2402: nerve entrapment, phleboliths.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|